Viewing Study NCT05199103


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2025-12-29 @ 10:12 AM
Study NCT ID: NCT05199103
Status: UNKNOWN
Last Update Posted: 2022-01-20
First Post: 2021-12-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Antithymocyte Globulin as a Second Line Therapy in Graves Orbitopathy
Sponsor: Medical University of Silesia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module